Geramizadeh Bita, Foroughi Razieh, Shojazadeh Alireza
Department of Pathology, Medical School of Shiraz University, Shiraz University of Medical Sciences, Shiraz, Iran.
Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Gastrointest Tumors. 2021 Apr;8(2):96-100. doi: 10.1159/000513962. Epub 2021 Mar 11.
Hepatocellular malignant neoplasm, not otherwise specified (HEM, NOS), is a rare liver tumor that is most commonly seen in adolescents. To the best of our knowledge, there has been no published review on this rare tumor in the English literature so far.
In this review, we will discuss all reported details, including demographic findings, clinical presentations, molecular histogenesis, imaging, gross pathology and histopathology, immunohistochemical findings, treatment modalities, and outcome, of the published cases of HEM, NOS, in the liver.
Twenty-two cases of HEM, NOS, have been reported in the last 10 years in the English literature. This tumor produces a large liver mass and is characteristically seen in adolescents presenting with right upper quadrant pain. Histologically, HEM, NOS, is a nonbiliary hepatocytic tumor with a biphasic pattern, that is, a mixture of 2 components of hepatocellular carcinoma and hepatoblastoma (HBL). There is no characteristic immunohistochemical feature for this tumor. Imaging findings are also not specific. Treatment of this tumor needs extensive surgery or even liver transplantation. Most of the cases in the literature were treated with the primary diagnosis of HBL, so pathologists, onco-surgeons, and oncologists should get familiar with this tumor to provide better treatment options. More case series with more follow-ups are necessary for the definite determination of the outcome of this tumor as a unique entity.
未另行指定的肝细胞恶性肿瘤(HEM,NOS)是一种罕见的肝脏肿瘤,最常见于青少年。据我们所知,迄今为止英文文献中尚无关于这种罕见肿瘤的综述发表。
在本综述中,我们将讨论已发表的肝脏HEM,NOS病例的所有报告细节,包括人口统计学结果、临床表现、分子组织发生、影像学、大体病理学和组织病理学、免疫组化结果、治疗方式及预后。
在过去10年的英文文献中已报道了22例HEM,NOS。这种肿瘤会产生较大的肝脏肿块,典型表现为青少年出现右上腹疼痛。组织学上,HEM,NOS是一种具有双相模式的非胆管肝细胞肿瘤,即肝细胞癌和肝母细胞瘤(HBL)两种成分的混合。该肿瘤没有特征性的免疫组化特征。影像学表现也不具有特异性。这种肿瘤的治疗需要广泛手术甚至肝移植。文献中的大多数病例最初诊断为HBL,因此病理学家、肿瘤外科医生和肿瘤学家应熟悉这种肿瘤,以提供更好的治疗选择。需要更多的病例系列及更长时间的随访,才能明确确定这种肿瘤作为一个独特实体的预后。